Maine Medical Center’s parent company secured a $5.1 million federal research grant to offer up to 85 Maine cancer patients access to clinical trials—offering clinical research as a care options for Maine. MaineHealth received the 6-year grant from the National Cancer Institute to help establish the MaineHealth Cancer Care Network Lifespan Program.
The recent program follows a $16.8 million deal where the Jackson Laboratory in Bar Harbor partnered with the Harold Alfond Foundation and all of Maine’s major hospitals to open up clinical research for genomics cancer treatments throughout Maine communities. The initiative supports approximately 1,800 Maine cancer patients to participate in genomics-based clinical trials. These studies are based on the use of genetic mapping for precision treatment that attacks the DNA of cancer cells.
MaineHealth targets 85 patients but cannot be sure how many they can get through clinical trials. In the past to access immunotherapy trials, Maine residents had to travel extensively to Boston, New York or Washington DC for major clinical trial opportunities. Now with these federal grants, Maine residents will be able to participate in advanced, net-generation medicine-based research right in their backyard.
Participating Hospitals: Clinical Trials come to Maine’s Community
Hospitals that will participate in the clinical trials include the following: Maine General Medical Center, Augusta; Southern Maine Health Care, Biddeford; Stephens Memorial Hospital in Norway; Waldo County General Hospital, Belfast; Pen Bay Medical Center, Rockport; St. Mary’s Regional Medical Center, Lewiston; Mid Coast Hospital, Brunswick; Franklin Memorial Hospital, Farmington; LincolnHealth, Damariscotta; and Memorial Hospital in North Conway, New Hampshire.
MaineHealth Cancer Care Network
Dr. Scot Remick, Maine Medical Center’s chief oncology
Dr. Christopher Darus, MaineHealth’s chair of oncology protocol review
Call to Action: Are you or a loved one based in Maine and diagnosed with a cancer? If so, look into available studies within the Maine hospitals. Moreover, tap into and access TrialSite Network concierge services. Finally, if you are a sponsor seeking partnerships for oncology studies in New England, we invite you to consider this clinical trials network.Source: Press Herald